`

Tagged: Early Clinical Development

Small molecule mediated targeting provides alternative strategies for polypharmacology, systems biology and personalized medicine.

September 7th, 2021 | Early Clinical Development

Most ongoing research and clinical programs have precision medicine at the core. BBCR can assist in a number of areas in relation to precision medicine, including small molecule research, including: Strategic drug assessment Early Clinical Development Regulatory consultant FDA meeting and submission Pre-IND integrated development plan Clinical consultant Clinical study design and protocol CRO and […]

BBCR has experience in biologics for rare diseases and can assist with the development of a targeted strategy to meet your study needs.

March 24th, 2021 | Early Clinical Development

Biologic treatments show promise in providing clinical solutions to a variety of diseases including rare cancers and precision medicine. Services include: Indications analysis and prioritization Strategic drug assessment Clinical study design and protocol Biomarker strategy Early Clinical Development FDA meeting and submission Pre-ND integrated development plan CRO and project management Study remediation and rescue   […]